Get notified when PHGE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsBiomX stockholders approve equity plan authorizing 1.39M shares with 4% annual increases
Filed April 10, 2026 · Period ending April 10, 2026 · ~1 min read
Key Changes
-
medium
Stockholders approved the 2026 Equity Incentive Plan authorizing 1,390,000 shares for employee compensation, with automatic annual increases of 4% of outstanding shares for ten years. This creates potential dilution of approximately 21% initially, growing annually.
Item 5.07: Special Meeting Results verify on EDGAR → -
low
The proposal passed with 3,395,917 votes for and only 5,009 against at the April 10 special meeting. Approximately 52% of outstanding shares participated in the vote.
Item 5.07: Voting Results verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade PHGE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify